Chemocentryx (CCXI) Market Value Rose While PAW Capital Decreased Position; Hrt Financial …

… Holders, 1Q 2018 (CCXI); 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; …

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *